RNA Formulation Resources

1. Unpacking The Importance Of Lipid Nanoparticle Production Platforms 4/15/2024

   Batch processing platforms for LNPs lack efficiency, appropriate controls, and yield optimization. Continuous manufacturing platforms may address some of those issues.

2. Towards A Universal LNP Platform For Multiplex Engineering 6/19/2026

   Multiplex engineering of T cells for solid tumors requires precise delivery. Emerging LNP approaches enable co-delivery of RNA and DNA, offering a safer, more scalable path beyond viral vectors.

3. Where Can Novel Non-Viral Polymeric Delivery Agents Take Us? 1/18/2023

   Explore ongoing work to harness different types of HDR templates in order to build cutting-edge systems with the potential to enable point-of-care cell and gene therapy manufacture.

4. The Key To Accelerating RNA-LNP Drug Development 12/27/2023

   Learn about the drug development hurdles that must be overcome to deliver on the promise of mRNA.

5. mRNA Manufacturing And Formulation 11/15/2022

   From fermentation to formulation, mRNA manufacturing requires a toolbox of technologies, services, and expertise. Explore our portfolio of solutions for making, purifying, and formulating mRNA.

6. LNP Formulation For mRNA Delivery 2/15/2023

   Microfluidic mixing is one of the most effective means to formulate LNPs for its scalability and reproducibility. Explore LNP formulation, polishing, sterile filtration of mRNA-LNPs, and more.

7. Using Synthetic ssDNA And dsDNA Templates For CRISPR Editing 6/19/2026

   Synthetic ssDNA and dsDNA donor templates boost CRISPR precision, efficiency, and consistency. The right strategy reduces errors, increases HDR, and delivers more reliable results across applications.

8. Oligonucleotide Purification And Synthesis 1/27/2026

   Examine how a 21‑mer oligo was synthesized and purified through systematic resin screening, method optimization, and successful scale‑up to build reliable, high‑purity chromatography workflows.

9. Lipid Nanoparticle Library For Non-Viral Delivery Of mRNA And saRNA Towards Vaccine And Cell & Gene Therapy Applications 4/18/2022

   Explore this proprietary ionizable lipid library which has shown promising potency towards various applications involving cell therapy, protein replacement therapy and RNA-based Vaccines.

10. Is Standardization The Key To Scalable CGT? 3/2/2026

    Experts note CGT programs often struggle due to limited operational readiness; early standardization supports scalable, reproducible, regulatory‑ready development and helps prevent late‑stage bottlenecks.